Aurinia Pharmaceuticals Inc.
AUPH
Amendment
Ownership
9.20%
Total Shares
12,229,500
Issuer CIK
1600620
Event Date
Mar 22, 2026
Accepted
Mar 25, 2026, 04:15 PM
SEC EDGARView Original Filing
Reporting Persons (6)
Joint Filing
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | Other | 9.20% | 12,229,500 | 0 | 12,229,500 |
| KEVIN TANG | Individual | 9.20% | 12,229,500 | 0 | 12,229,500 |
| TANG CAPITAL PARTNERS, LP | Partnership | 5.30% | 6,990,461 | 0 | 6,990,461 |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | Partnership | 3.90% | 5,239,039 | 0 | 5,239,039 |
| TANG CAPITAL PARTNERS III, INC | CO | 0.00% | 0 | 0 | 0 |
| TANG CAPITAL PARTNERS IV, INC | CO | 0.00% | 0 | 0 | 0 |
Disclosure Items (2)
Security Title
Common Shares, no par value
Issuer Name
Aurinia Pharmaceuticals Inc.
Issuer Address
#140, 14315 - 118 Avenue, Edmonton, A0, T5L 4S6